Clinical Trial Update: Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates irinotecan liposomes with cetuximab and vermofenib in advanced metastatic colorectal cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Liposomal irinotecan (liposomal irinotecan)
• Vermofenib (vermofenib)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: RECRUITING